Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Poloxamer 188

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3ATOVAQUONE

    02 1BANZEL

    03 1FLO-PRED

    04 1MEPRON

    05 1TERIL

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    EISAI INC

    RUFINAMIDE

    arrow
    AACR Annual meeting
    Not Confirmed
    EISAI INC
    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RUFINAMIDE

    Drug : BANZEL

    Dosage Form : SUSPENSION; ORAL

    Application Number : 201367

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    GLAXOSMITHKLINE LLC

    ATOVAQUONE

    arrow
    AACR Annual meeting
    Not Confirmed
    GLAXOSMITHKLINE LLC
    United Kingdom
    arrow
    AACR Annual meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ATOVAQUONE

    Drug : MEPRON

    Dosage Form : SUSPENSION; ORAL

    Application Number : 20500

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    HETERO LABS LTD III

    ATOVAQUONE

    arrow
    AACR Annual meeting
    Not Confirmed
    HETERO LABS LTD III
    India
    arrow
    AACR Annual meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ATOVAQUONE

    Drug : ATOVAQUONE

    Dosage Form : SUSPENSION; ORAL

    Application Number : 210692

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    LUPIN LTD

    ATOVAQUONE

    arrow
    AACR Annual meeting
    Not Confirmed
    LUPIN LTD
    India
    arrow
    AACR Annual meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ATOVAQUONE

    Drug : ATOVAQUONE

    Dosage Form : SUSPENSION; ORAL

    Application Number : 209105

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    TARO

    CARBAMAZEPINE

    arrow
    AACR Annual meeting
    Not Confirmed
    TARO
    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CARBAMAZEPINE

    Drug : TERIL

    Dosage Form : SUSPENSION; ORAL

    Application Number : 76729

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    TARO

    PREDNISOLONE ACETATE

    arrow
    AACR Annual meeting
    Not Confirmed
    TARO
    U.S.A
    arrow
    AACR Annual meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PREDNISOLONE ACETATE

    Drug : FLO-PRED

    Dosage Form : SUSPENSION; ORAL

    Application Number : 22067

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    GLENMARK SPECLT

    ATOVAQUONE

    arrow
    AACR Annual meeting
    Not Confirmed
    GLENMARK SPECLT
    Country
    arrow
    AACR Annual meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ATOVAQUONE

    Drug : ATOVAQUONE

    Dosage Form : SUSPENSION; ORAL

    Application Number : 209685

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF